Evofem Biosciences, Inc.
|
10.35 USD
|
102.609%
|
Arch Therapeutics, Inc.
|
-2.27 USD
|
88.106%
|
CSL Limited
|
2.73 USD
|
109.89%
|
Santhera Pharmaceuticals Holding AG
|
5.95 USD
|
104.538%
|
Regen BioPharma, Inc.
|
0.26 USD
|
203.846%
|
BioStem Technologies, Inc.
|
-0.62 USD
|
56.452%
|
Capstone Therapeutics Corp.
|
-36.39 USD
|
99.258%
|
Qrons Inc.
|
-0.06 USD
|
-363.122%
|
Nascent Biotech, Inc.
|
-0.01 USD
|
-1914.925%
|
Northwest Biotherapeutics, Inc.
|
-0.06 USD
|
-369.565%
|
Oncotelic Therapeutics, Inc.
|
-0.02 USD
|
-1256.784%
|
Skye Bioscience, Inc.
|
-5.37 USD
|
94.972%
|
ProtoKinetix, Incorporated
|
-0.01 USD
|
-2600.0%
|
Rebus Holdings, Inc.
|
-0.03 USD
|
-741.121%
|
Acro Biomedical Co., Ltd.
|
-0.26 USD
|
-3.846%
|
Burzynski Research Institute, Inc.
|
-0.01 USD
|
-2547.059%
|
Genscript Biotech Corporation
|
-0.05 USD
|
-494.714%
|
Neon Bloom, Inc.
|
-0.00 USD
|
-17900.0%
|
Adynxx, Inc.
|
- USD
|
Infinity%
|
Eiger BioPharmaceuticals, Inc.
|
-50.78 USD
|
99.468%
|
Nanobac Pharmaceuticals, Incorporated
|
- USD
|
Infinity%
|
Institute of Biomedical Research Corp.
|
-0.05 USD
|
-424.272%
|
SQZ Biotechnologies Company
|
-2.76 USD
|
90.217%
|
Intellipharmaceutics International Inc.
|
-0.09 USD
|
-208.924%
|
Propanc Biopharma, Inc.
|
-0.02 USD
|
-1039.241%
|
Mesoblast Limited
|
-0.09 USD
|
-203.03%
|
Marizyme, Inc.
|
-1.44 USD
|
81.25%
|
Genus plc
|
0.12 USD
|
325.0%
|
VioQuest Pharmaceuticals, Inc.
|
-2.33 USD
|
88.412%
|
Pharming Group N.V.
|
-0.02 USD
|
-1577.019%
|
Therapeutic Solutions International, Inc.
|
-0.00 USD
|
-38471.429%
|
CNBX Pharmaceuticals Inc.
|
-0.42 USD
|
35.714%
|
Nymox Pharmaceutical Corporation
|
-0.10 USD
|
-179.793%
|
ContraFect Corporation
|
-124.97 USD
|
99.784%
|
PsyBio Therapeutics Corp.
|
-0.04 USD
|
-542.857%
|
Sienna Biopharmaceuticals, Inc.
|
- USD
|
Infinity%
|
RegeneRx Biopharmaceuticals, Inc.
|
-0.01 USD
|
-2150.0%
|
IMV Inc.
|
-4.37 USD
|
93.822%
|
AXIM Biotechnologies, Inc.
|
-0.04 USD
|
-662.712%
|
MultiCell Technologies, Inc.
|
-0.00 USD
|
-269900.0%
|
ONE Bio Corp.
|
1.43 USD
|
118.881%
|
Accustem Sciences Inc.
|
-0.34 USD
|
20.588%
|
RVL Pharmaceuticals plc
|
-0.58 USD
|
53.448%
|
Arno Therapeutics, Inc.
|
- USD
|
Infinity%
|
EV Biologics, Inc.
|
-0.12 USD
|
-125.0%
|
Q BioMed Inc.
|
-0.08 USD
|
-245.711%
|
Emmaus Life Sciences, Inc.
|
-0.07 USD
|
-284.068%
|
Mosaic ImmunoEngineering Inc.
|
-0.33 USD
|
18.182%
|
Biomind Labs Inc.
|
-0.02 USD
|
-1566.667%
|
American Oriental Bioengineering, Inc.
|
-781.24 USD
|
99.965%
|
Provectus Biopharmaceuticals, Inc.
|
-0.01 USD
|
-3548.649%
|
TetraLogic Pharmaceuticals Corporation
|
- USD
|
Infinity%
|
GlobeStar Therapeutics Corporation
|
-0.00 USD
|
-11150.0%
|
THC Farmaceuticals, Inc.
|
-0.00 USD
|
-33650.0%
|
Curative Biotechnology, Inc.
|
-0.01 USD
|
-2968.182%
|
GB Sciences, Inc.
|
-0.00 USD
|
-6485.366%
|
Alpha Cognition Inc.
|
-0.15 USD
|
-80.0%
|
HST Global, Inc.
|
-0.03 USD
|
-867.742%
|
Wesana Health Holdings Inc.
|
-0.05 USD
|
-438.922%
|
Halberd Corporation
|
-0.00 USD
|
-269900.0%
|
Enzolytics Inc.
|
-0.00 USD
|
-38471.429%
|
Agentix Corp.
|
-0.04 USD
|
-671.429%
|
Resverlogix Corp.
|
-0.01 USD
|
-1801.408%
|
Nuo Therapeutics, Inc.
|
-0.08 USD
|
-258.09%
|
MetaStat, Inc.
|
- USD
|
Infinity%
|
argenx SE
|
-5.16 USD
|
94.767%
|
Enzon Pharmaceuticals, Inc.
|
0.00 USD
|
20869.231%
|
Endonovo Therapeutics, Inc.
|
0.03 USD
|
1175.697%
|
RespireRx Pharmaceuticals Inc.
|
-0.04 USD
|
-656.303%
|
GeneThera, Inc.
|
- USD
|
Infinity%
|
Inhibitor Therapeutics, Inc.
|
-0.02 USD
|
-1250.0%
|
AVAX Technologies, Inc.
|
-0.05 USD
|
-400.928%
|
Zenith Capital Corp.
|
-0.07 USD
|
-286.266%
|
Ember Therapeutics, Inc.
|
-0.01 USD
|
-4185.714%
|
Anthera Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
Sigyn Therapeutics, Inc.
|
-3.77 USD
|
92.838%
|
WPD Pharmaceuticals Inc.
|
-0.00 USD
|
-53900.0%
|
Cotinga Pharmaceuticals Inc.
|
-0.09 USD
|
-195.728%
|
Kadimastem Ltd
|
-0.78 USD
|
65.385%
|
Helix BioMedix, Inc.
|
-4.70 USD
|
94.255%
|
VitaSpring Biomedical Co. Ltd.
|
- USD
|
Infinity%
|
Oncology Pharma Inc.
|
- USD
|
Infinity%
|
Reve Technologies, Inc.
|
-0.01 USD
|
-2168.908%
|
LadRx Corporation
|
0.68 USD
|
139.706%
|
Cell Source, Inc.
|
-0.17 USD
|
-58.824%
|
Regen BioPharma, Inc.
|
0.29 USD
|
193.103%
|
NovAccess Global Inc.
|
-0.23 USD
|
-17.391%
|
Affymax, Inc.
|
-0.39 USD
|
30.769%
|
Itoco Inc.
|
-0.01 USD
|
-3452.632%
|
Rasna Therapeutics, Inc.
|
-0.01 USD
|
-2600.0%
|
Pathfinder Cell Therapy, Inc.
|
-0.00 USD
|
-10700.0%
|
Mobile Lads Corp.
|
-0.01 USD
|
-4721.429%
|
CytoDyn Inc.
|
-0.05 USD
|
-410.397%
|
Claritas Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
NDT Pharmaceuticals Inc.
|
-0.00 USD
|
-53900.0%
|
NanoSphere Health Sciences Inc.
|
-0.02 USD
|
-1116.216%
|
Alseres Pharmaceuticals, Inc.
|
-153.67 USD
|
99.824%
|
SYBLEU INC
|
-0.02 USD
|
-1442.857%
|
Advanced Proteome Therapeutics Corporation
|
- USD
|
Infinity%
|
ImmunoCellular Therapeutics, Ltd.
|
-0.01 USD
|
-1801.408%
|
International Stem Cell Corporation
|
-0.02 USD
|
-1546.341%
|
Bioxytran, Inc.
|
-0.03 USD
|
-746.395%
|
GlobeImmune, Inc.
|
- USD
|
Infinity%
|
Predictive Technology Group, Inc.
|
- USD
|
Infinity%
|
ProText Mobility, Inc.
|
- USD
|
Infinity%
|
Cardax, Inc.
|
- USD
|
Infinity%
|
VG Life Sciences Inc.
|
-0.00 USD
|
-269900.0%
|
Kaleido Biosciences, Inc.
|
- USD
|
Infinity%
|
Advaxis, Inc.
|
-7.99 USD
|
96.621%
|
Adhera Therapeutics, Inc.
|
-1.18 USD
|
77.119%
|
RenovaCare, Inc.
|
- USD
|
Infinity%
|
Regnum Corp.
|
-0.03 USD
|
-694.118%
|
Innovation Pharmaceuticals Inc.
|
-0.01 USD
|
-4185.714%
|
Neutra Corp.
|
-0.00 USD
|
-269900.0%
|
Windtree Therapeutics, Inc.
|
-94.23 USD
|
99.713%
|
PureTech Health plc
|
-2.38 USD
|
88.655%
|
Coeptis Therapeutics, Inc.
|
-0.83 USD
|
67.47%
|
IXICO plc
|
-0.02 USD
|
-1006.557%
|
IntelGenx Technologies Corp.
|
-0.06 USD
|
-375.352%
|
Gelesis Holdings, Inc.
|
-1.35 USD
|
80.0%
|
CSL Limited
|
5.47 USD
|
104.936%
|
Cellectis S.A.
|
-1.77 USD
|
84.746%
|